1-8 of 8
Authors: Jonas Bjerring Olesen
Journal Article
Efficacy and safety of oral anticoagulants according to kidney function among patients with atrial fibrillation
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 3, April 2024, Pages 210–218, https://doi.org/10.1093/ehjcvp/pvae016
Published: 24 February 2024
Journal Article
Discontinuation of direct oral anticoagulants among patients with atrial fibrillation according to gender and cohabitation status: a nationwide cohort study
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 4, July 2022, Pages 353–362, https://doi.org/10.1093/ehjcvp/pvab065
Published: 20 August 2021
Journal Article
Assessing absolute stroke risk in patients with atrial fibrillation using a risk factor-based approach
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue FI1, April 2021, Pages f3–f10, https://doi.org/10.1093/ehjcvp/pvaa063
Published: 12 June 2020
Journal Article
All-cause mortality, stroke, and bleeding in patients with atrial fibrillation and valvular heart disease
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue FI1, April 2021, Pages f93–f100, https://doi.org/10.1093/ehjcvp/pvaa011
Published: 17 February 2020
Journal Article
Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 5, September 2020, Pages 292–300, https://doi.org/10.1093/ehjcvp/pvz069
Published: 19 November 2019
Journal Article
Switching from vitamin K antagonist to dabigatran in atrial fibrillation: differences according to dose
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 1, January 2021, Pages 20–30, https://doi.org/10.1093/ehjcvp/pvz066
Published: 15 November 2019
Journal Article
Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 4, October 2018, Pages 220–227, https://doi.org/10.1093/ehjcvp/pvy021
Published: 26 June 2018
Journal Article
Thiazolidinediones are associated with a decreased risk of atrial fibrillation compared with other antidiabetic treatment: a nationwide cohort study
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 3, Issue 3, July 2017, Pages 140–146, https://doi.org/10.1093/ehjcvp/pvw036
Published: 08 November 2016
